Rowland Carmichael Advisors’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-32,679
Closed -$1.07M 344
2018
Q3
$1.07M Sell
32,679
-865
-3% -$27.5K 0.42% 52
2018
Q2
$1.04M Sell
33,544
-3,635
-10% -$104K 0.44% 45
2018
Q1
$1M Buy
37,179
+5,805
+19% +$155K 0.55% 44
2017
Q4
$864K Buy
31,374
+9,853
+46% +$284K 0.44% 68
2017
Q3
$687K Buy
21,521
+200
+0.9% +$6.41K 0.38% 80
2017
Q2
$704K Buy
21,321
+2,242
+12% +$74.2K 0.41% 80
2017
Q1
$629K Buy
19,079
+1,500
+9% +$48.2K 0.38% 85
2016
Q4
$550K Buy
17,579
+6,756
+62% +$209K 0.32% 99
2016
Q3
$384K Buy
10,823
+4,357
+67% +$155K 0.25% 127
2016
Q2
$220K Sell
6,466
-200
-3% -$6.67K 0.14% 202
2016
Q1
$235K Buy
+6,666
New +$218K 0.22% 122

Other funds holding OHI

Rowland Carmichael Advisors's OHI Position: Q4 2018 in Review

Rowland Carmichael Advisors sold out of Omega Healthcare (OHI) in Q4 2018, closing a stake of 32,679 shares — an estimated $1.07M sold.

Rowland Carmichael Advisors first reported a position in OHI in Q1 2016 and held it in 11 quarters. The position peaked at $1.07M in Q3 2018. 459 funds tracked by Wall St. Rank hold OHI as of Q4 2018.

  • Rowland Carmichael Advisors reported no remaining Omega Healthcare position as of Q4 2018 after selling out during the quarter.
  • Rowland Carmichael Advisors sold 32,679 Omega Healthcare shares in Q4 2018, an estimated $1.07M.
  • Rowland Carmichael Advisors first reported a position in Omega Healthcare in Q1 2016 and held it in 11 quarters.
  • Rowland Carmichael Advisors's Omega Healthcare position peaked at $1.07M in Q3 2018.
  • 459 funds tracked by Wall St. Rank held Omega Healthcare as of Q4 2018.

Based on Rowland Carmichael Advisors's 13F filing for Q4 2018, filed 10 Feb 2020.